VIBES

Volatile Non-Invasive Biomarkers of Epileptic Seizures

Currently Active
Cancer Focus
Epilepsy (Neurological)
Sponsor
University College London (UCL)
Funding
Epilepsy Research Institute UK, MRC
ClinicalTrials.gov

Background

Approximately 20–30% of patients are misdiagnosed with epilepsy. The gold standard ictal video EEG is not readily available in emergency settings. Seizure unpredictability poses daily challenges for people with epilepsy. Research has shown that dogs can predict oncoming seizures and differentiate between seizure and exercise samples, suggesting a possible 'odour' linked to seizures. This study investigates VOCs in breath and skin as potential diagnostic and predictive biomarkers for epileptic seizures. In collaboration with Prof. Matthew Walker and Dr. Eleonora Lugará at UCL.

VIBES

Currently Recruiting

Aims

  1. Define a VOC panel in breath and skin that distinguishes between epileptic and non-epileptic seizures
  2. Identify VOCs whose concentrations change prior to seizure onset

Methods

Prospective cohort study at the National Hospital for Neurology and Neurosurgery (NHNN) telemetry unit and Chalfont Centre for Epilepsy. 100 participants in seizure cohorts (epileptic and non-epileptic) plus 50 age-matched healthy controls. Breath and skin VOC samples collected using standardised protocols around seizure events.

Participation

Recruitment to this trial takes place through participating NHS centres. If you think you may be eligible, please speak with your GP or hospital clinician who can refer you through the appropriate pathway.

Healthcare professional enquiries: Ilaria Belluomo

← Back to All Trials